Overview

Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome

Status:
Completed
Trial end date:
2006-01-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to exploratively investigate the clinical efficacy of rebamipide on dry mouth in patients with Sjögren's syndrome in comparison with placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Rebamipide